Dashboard
Unrated Stock - No Analysis Available
Stock DNA
Pharmaceuticals & Biotechnology
PLN 5,715 Million (Mid Cap)
22.00
NA
0.00%
1.21
45.18%
9.45
Revenue and Profits:
Net Sales:
683 Million
(Quarterly Results - Jun 2026)
Net Profit:
60 Million
Total Returns (Price + Dividend) 
Company does not have enough history
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
6.90%
EBIT Growth (5y)
-13.71%
EBIT to Interest (avg)
5.55
Debt to EBITDA (avg)
1.25
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
318.93
Tax Ratio
16.82%
Dividend Payout Ratio
59.03%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
29.07%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
22
Industry P/E
Price to Book Value
9.78
EV to EBIT
17.41
EV to EBITDA
11.20
EV to Capital Employed
4.98
EV to Sales
2.67
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
28.59%
ROE (Latest)
45.18%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bearish
RSI
Bullish
No Signal
Bollinger Bands
Bearish
Sideways
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Mildly Bullish
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Jun'26 - QoQ
Jun'26
Mar'26
Change(%)
Net Sales
683.00
670.90
1.80%
Operating Profit (PBDIT) excl Other Income
151.90
169.70
-10.49%
Interest
16.30
16.90
-3.55%
Exceptional Items
-0.10
0.00
Consolidate Net Profit
60.50
85.90
-29.57%
Operating Profit Margin (Excl OI)
135.50%
168.60%
-3.31%
USD in Million.
Net Sales
QoQ Growth in quarter ended Jun 2026 is 1.80% vs 8.51% in Mar 2026
Consolidated Net Profit
QoQ Growth in quarter ended Jun 2026 is -29.57% vs 118.58% in Mar 2026
Annual Results Snapshot (Consolidated) - Dec'25
Dec'25
Dec'24
Change(%)
Net Sales
2,410.50
1,950.10
23.61%
Operating Profit (PBDIT) excl Other Income
580.90
481.00
20.77%
Interest
68.10
56.30
20.96%
Exceptional Items
-6.70
14.00
-147.86%
Consolidate Net Profit
261.90
232.00
12.89%
Operating Profit Margin (Excl OI)
157.30%
163.80%
-0.65%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2025 is 23.61% vs 22.80% in Dec 2024
Consolidated Net Profit
YoY Growth in year ended Dec 2025 is 12.89% vs 78.46% in Dec 2024
Footer loading






